Lu Chen is a core member of the Health Care practice area at Boston Consulting Group. She specializes in working with clients in the pharmaceutical industry across segments including innovative pharma, specialty pharma, generics, and biosimilars.

Lu has extensive experience working with clients on CEO transitions, corporate strategy, portfolio strategy, corporate development and M&A (including commercial due diligence), portfolio and pipeline valuation, market entry strategy, go-to-market model, supply chain strategy, large scale transformation, business model innovation, and other areas. She has worked with global pharma and generics clients, as well as Asia-specific companies. Her work has also covered pricing, and PMI.

Before joining BCG, Lu worked as Postdoctoral Fellow at Mayo Clinic and Baylor College of Medicine, focusing on oncology research.


  • PhD, Molecular Biology, University of Texas, Medical Branch
  • MBA, Health Care Management, Wharton School of the University of Pennsylvania
  • BS, Microbiology, Fudan University